Literature DB >> 12948328

Prevalence of drooling in children with cerebral palsy attending special schools.

J F Tahmassebi1, M E J Curzon.   

Abstract

Prevalence of drooling in children with cerebral palsy (CP) and its severity across dental age (i.e. children with primary, mixed, and permanent dentitions) was investigated. One hundred and sixty children and adolescents (91 males, 69 females; mean age 10 years 10 months, SD 4 years 2 months; range 4 to 18 years) with CP who attended special schools were involved in this study. Sixty eight per cent of participants had spastic CP with the majority (45%) diagnosed as having quadriplegia. Presence or absence of drooling was determined by direct observation of the participants. Other data, such as age, sex, learning disability, and type of CP were collected using questionnaires. Results showed 93 of 160 children (58%) with CP had a drooling condition and of these 53 (33%) had severe drooling. It was found that the degree of drooling decreased as the child's dental age increased. Prevalence of drooling in children with primary dentition was found to be 75% as compared with 43% of those with permanent dentition, although this difference was not statistically significant. It was concluded that any invasive treatment to reduce drooling should, perhaps, be postponed until the child's oromusculature has matured.

Entities:  

Mesh:

Year:  2003        PMID: 12948328     DOI: 10.1017/s0012162203001117

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  16 in total

1.  Effect of botulinum toxin type a on morphology of salivary glands in patients with cerebral palsy.

Authors:  Zee-Ihn Lee; Dong-Hyun Cho; Won-Duck Choi; Dong-Hwi Park; Seung-Deuk Byun
Journal:  Ann Rehabil Med       Date:  2011-10-31

2.  Cariogram Model in Assessment of Dental Caries among Mentally Challenged and Visually Impaired Individuals of Udaipur, India.

Authors:  Hemasha Daryani; Ramesh Nagarajappa; Archana J Sharda; Kailash Asawa; Mridula Tak; Sudhanshu Sanadhya; Mehak Batra
Journal:  J Clin Diagn Res       Date:  2014-01-12

3.  Social interaction and self-esteem of children with cerebral palsy after treatment for severe drooling.

Authors:  Jan J W van der Burg; Peter H Jongerius; Jacques van Limbeek; Karen van Hulst; Jan J Rotteveel
Journal:  Eur J Pediatr       Date:  2005-09-20       Impact factor: 3.183

4.  Bilateral submandibular duct relocation by high-frequency radiosurgery.

Authors:  Gábor Katona; Zsuzsa Csákányi; Anikó Lorincz; Imre Gerlinger
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-05       Impact factor: 2.503

5.  Management of drooling for patients in the north of Iran: Analysis of the surgical management.

Authors:  Seyed Ebrahim Naghavi; Mir Mohammad Jalali
Journal:  J Res Med Sci       Date:  2010-01       Impact factor: 1.852

6.  Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions.

Authors:  Robert S Zeller; Hak-Myung Lee; Paul F Cavanaugh; Jennifer Davidson
Journal:  Ther Clin Risk Manag       Date:  2012-01-25       Impact factor: 2.423

7.  Oral manifestation in mentally challenged children.

Authors:  V K Rahul; Cinil Mathew; Sunil Jose; George Thomas; M C Noushad; T P Mohammed Feroz
Journal:  J Int Oral Health       Date:  2015-02

Review 8.  Cerebral palsy: a dental update.

Authors:  Nidhi Sehrawat; Mohita Marwaha; Kalpana Bansal; Radhika Chopra
Journal:  Int J Clin Pediatr Dent       Date:  2014-08-29

9.  Inequalities in oral health for children with disabilities: a French national survey in special schools.

Authors:  Martine Hennequin; Véronique Moysan; Didier Jourdan; Martine Dorin; Emmanuel Nicolas
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

10.  The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.

Authors:  Jeremy R Parr; Emma Weldon; Lindsay Pennington; Nick Steen; Jane Williams; Charlie Fairhurst; Anne O'Hare; Raj Lodh; Allan Colver
Journal:  Trials       Date:  2014-02-17       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.